ms variance – rachel dorsey-campbell: dmt monitoring
Published 5 years ago • 122 plays • Length 7:49Download video MP4
Download video MP3
Similar videos
-
1:00:00
q&a with your ms pharmacist about dmts | joela mathews & rachel dorsey-campbell, ms academy
-
14:24
dmt safety issues | ean 2020 summary by multiple sclerosis academy
-
15:34
ms variance – joela mathews: the role of the ms pharmacist
-
21:47
ms variance – dr gordon mazibrada: implementing the nhse stopping criteria for dmts
-
1:04:24
#mscovid19 question time: 03/04/2020 | prof jeremy hobart, rachel dorsey-campbell & sarah white
-
7:52
ms drug showdown: which medications are the best?
-
59:04
medication maximization in parkinson disease
-
28:14
ending ms progression: research advances that could lead to breakthrough treatments
-
1:14:47
formalising remote management of multiple sclerosis | ms academy #mscovid19
-
2:34
ms treatment guidelines & the role of dmts
-
44:13
spms: difficult discussions in progressive ms | ms academy webinar
-
33:40
progressive ms & starting and switching dmts – part 2 | ean 2020 summary by ms academy
-
1:00:08
#mscovid19 question time: 27/03/20 | g giovannoni, d martin, g pepper, p anderson, r dorsey-campbell
-
35:50
parkinson’s disease & you: brain rhythms as potential biomarkers in parkinson's disease
-
3:19
chariotms: the first dmt trial in advanced multiple sclerosis
-
40:44
harnessing the full potential of dmt mechanisms of action to improve ms outcomes
-
47:20
ms academy webinar: ageing and ms
-
13:56
starting & switching dmts | ean 2020 summary by multiple sclerosis academy
-
3:29
ask the md: parkinson's diagnosis and biomarkers
-
0:47
when to make a timely switch to high-efficacy dmt for ms